Astrid Borkowski - Apr 28, 2022 Form 3 Insider Report for HilleVax, Inc. (HLVX)

Role
Chief Medical Officer
Signature
/s/ Paul Bavier, Attorney-in-fact
Stock symbol
HLVX
Transactions as of
Apr 28, 2022
Transactions value $
$0
Form type
3
Date filed
4/28/2022, 09:45 PM
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HLVX Common Stock 168K Apr 28, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of restricted stock subject to repurchase by the Issuer.

Remarks:

Exhibit 24 - Power of Attorney.